Stock Rich List
Nasdaq: ARWR

Arrowhead Pharmaceuticals insiders

The officers, directors and 10% owners of Arrowhead Pharmaceuticals, Inc. who hold the most stock, valued at the live ARWR price.

$43.65
ARWR today +$540K (+1.25%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
11
Their ARWR stock
$254M
Market value
$6.15B
Held by ranked insiders
4.14%

Insiders by value of ARWR holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Christopher AnzaloneChief Executive Officer3,792,739$166M2.69%1025th
2Patrick O'BrienCOO547,408$23.9M0.39%4533rd
3Kenneth MyszkowskiChief Financial Officer455,433$19.9M0.32%5216th
4James HamiltonChief Medical Officer226,958$9.9M0.16%8850th
5Javier San MartinChief Medical Officer198,497$8.7M0.14%9742nd
6Daniel Joseph ApelChief Financial Officer162,905$7.1M0.12%11271st
7Tracie OliverChief Commercial Officer127,107$5.5M<0.1%13467th
8Douglas B. GivenDirector124,167$5.4M<0.1%13677th
9Michael PerryDirector111,459$4.9M<0.1%9889th
10Douglas S. IngramDirector46,215$2.0M<0.1%6386th
11Backer Marianne DeDirector31,267$1.4M<0.1%8334th

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Arrowhead Pharmaceuticals; see each profile for the filing.